Increased Systemic and Local Interleukin 9 Levels in Patients with Carotid and Coronary Atherosclerosis
Open Access
- 30 August 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8) , e72769
Abstract
Atherosclerosis is a chronic inflammatory disorder that involves a range of inflammatory mediators. Although interleukin (IL)-9 has been related to inflammation, there are at present no data on its role in atherosclerosis. Here we have examined IL-9 and IL-9 receptor (IL-9R) systemically and locally in patients with coronary and carotid atherosclerosis. Plasma IL-9 was quantified by enzyme immunoassay and multiplex technology. IL-9 and IL-9R mRNA were quantified by real-time RT-PCR, and their localization within the lesion was assessed by immunohistochemistry. The main findings were: (i) Patients with carotid atherosclerosis had significantly raised IL-9 plasma levels compared with healthy controls (n = 28), with no differences between asymptomatic (n = 56) and symptomatic (n = 88) patients. (ii) On admission, patients with acute ST-elevation myocardial infarction (STEMI) (n = 42) had markedly raised IL-9 plasma levels which gradually declined during the first week post-MI. (iii) T cells and monocytes from patients with unstable angina (n = 17) had increased mRNA levels of IL-9 as compared with controls (n = 11). (iv) Carotid plaques (n = 68) showed increased mRNA levels of IL-9 and IL-9R compared to non-atherosclerotic vessels (n = 10). Co-localization to T cells (IL-9 and IL-9R) and macrophages (IL-9) were shown by immunohistochemistry. (v) IL-9 increased IL-17 release in peripheral blood mononuclear cells from patients with unstable angina (n = 5) and healthy controls (n = 5) with a particularly enhancing effect in cells from the patient group. Our findings show increased IL-9 levels in different atherosclerotic disorders both systemically and within the lesion, suggesting a role for the IL-9/IL-9R axis in the atherosclerotic process, potentially involving IL-17 mediated mechanisms. However, the functional consequences of these findings should be further investigated.Keywords
This publication has 30 references indexed in Scilit:
- Involvement of IL-9 in Th17-Associated Inflammation and Angiogenesis of PsoriasisPLOS ONE, 2013
- Inflammation in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- IL-33 Induces IL-9 Production in Human CD4+ T Cells and BasophilsPLOS ONE, 2011
- Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-γ in patients with chronic heart failureJournal of Translational Medicine, 2011
- Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volumeJournal of Neurology, 2011
- The Chemokine Network in Relation to Infarct Size and Left Ventricular Remodeling Following Acute Myocardial InfarctionThe American Journal of Cardiology, 2009
- IL-9 induces differentiation of T H 17 cells and enhances function of FoxP3 + natural regulatory T cellsProceedings of the National Academy of Sciences, 2009
- IL-9 as a mediator of Th17-driven inflammatory diseaseJournal of Experimental Medicine, 2009
- C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarctionEuropean Heart Journal, 2009
- IL-9 expression by human eosinophils: Regulation by IL-1β and TNF-αJournal of Allergy and Clinical Immunology, 2000